HISTORY, DEVELOPMENT AND CORPORATE STRUCTURE

3.

4.

These refer to all Pre-IPO Investors excluding Onshore Pre-IPO Investors (as defined in the paragraph headed
“– Corporate Reorganization”).

Of the 90,100,040 Shares held by Great Biono Fortune LP, Dr. De-Chao Michael Yu is beneficially interested
in 59,511,000 Shares and Mr. Ronald Hao Xi Ede is beneficially interested in 9,539,040 Shares, in their
capacity as limited partners of Great Biono Fortune LP. The beneficial interest in the remaining 21,050,000
Shares held by Great Biono Fortune LP is held by 10 individual employees of the Company in their capacity
as limited partners, including Dr. Qinwei Zhou, our Chief Operation Officer, who is beneficially interested in
5,000,000 of these remaining Shares.

5.

These are the Onshore Pre-IPO Investors (as defined in the paragraph headed “– Corporate Reorganization”).

OUR STRUCTURE IMMEDIATELY FOLLOWING THE GLOBAL OFFERING

The following chart depicts our shareholding structure immediately following the
completion of the Global Offering, assuming that all of the Preferred Shares have been
converted to ordinary shares on a 1:1 basis and the Over-allotment Option is not exercised and
no shares are issued pursuant to the Equity Plans:

Certain of our

Directors(1)

Individual shareholders(2)

Other Pre-IPO

Investors(3)

Great Biono
Fortune LP(4)

Onshore 

Pre-IPO Investors(5)

Cornerstone investments 
of existing shareholders 

or their affiliates(6)

Other public
shareholders

4.98%

1.37%

47.73%

8.06%

16.72%

4.76%

16.38%

100%

Innovent Biologics

(USA), Inc.

(Delaware, USA)

The Company

(Cayman) 

100%

Innovent HK
(Hong Kong)

97.14%

100%

Oriza Xinda
International

Limited
(Cayman)

2.86%

Innovent Suzhou

(PRC)

100%

Suzhou Innovent Biotechnology

(PRC)

Offshore

Onshore

Notes:

1.

The Directors with interests in the Company are Dr. De-Chao Michael Yu (4.98%) and Dr. Charles Leland
Cooney who holds 39,090 Shares. Dr. Yu’s aggregate shareholding in the Company is 145,728,230 Shares
(13.03%), including 45,628,190 (4.08%) directly held Shares, 10,000,000 Shares (0.89%) held by Gloria
Bingqinzi Yu as trustee of the Yu Tong Family Irrevocable Trust, of which Dr. Yu and his spouse are the
grantors, and 90,100,040 (8.06% Shares held by Great Biono Fortune LP, the general partner of which is
wholly-owned by Dr. Yu (please refer to Note 3 below for more information on Great Biono Fortune LP). Dr.
Yu is a substantial shareholder of the Company for the purposes of the Listing Rules. For more details
regarding Dr. Yu’s interests, please refer to the section headed “Substantial Shareholders” in this prospectus.

2.

These individual shareholders are Scott Matthew Wheelwright (0.33%), Chen Keqin (0.22%), Kent Stephen
Iverson (0.13%), Donald Franklin Gerson (0.09%), Kevin Kai Wen Yang (0.01%), Wei Li (0.18%), Kwan Chat
Ming (0.08%), and Zheng Jia (0.33%). All of these individual shareholders are Independent Third Parties and
independent from each other.

– 213 –

